SCA
OCGN icon

Southpoint Capital Advisors’s Ocugen OCGN Stock Holding History

Southpoint Capital Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,000,000
Closed -$9.9M – 54
2022
Q1 		$9.9M Buy
3,000,000
+1,645,290
+121% +$5.78M 0.19% 49
2021
Q4 		$6.16M Buy
+1,354,710
New +$10.2M 0.12% 47

Other funds holding OCGN

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Southpoint Capital Advisors's OCGN Position: Q2 2022 in Review

Southpoint Capital Advisors sold out of Ocugen (OCGN) in Q2 2022, closing a stake of 3,000,000 shares — an estimated $9.9M sold.

Southpoint Capital Advisors first reported a position in OCGN in Q4 2021 and held it in 2 quarters. The position peaked at $9.9M in Q1 2022. 124 funds tracked by Wall St. Rank hold OCGN as of Q2 2022.

  • Southpoint Capital Advisors reported no remaining Ocugen position as of Q2 2022 after selling out during the quarter.
  • Southpoint Capital Advisors sold 3,000,000 Ocugen shares in Q2 2022, an estimated $9.9M.
  • Southpoint Capital Advisors first reported a position in Ocugen in Q4 2021 and held it in 2 quarters.
  • Southpoint Capital Advisors's Ocugen position peaked at $9.9M in Q1 2022.
  • 124 funds tracked by Wall St. Rank held Ocugen as of Q2 2022.

Based on Southpoint Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.